Skip to content
MarketScale
‹ Back to IndustriesHealthcare

M&A Healthcare Advisors (MAHA) Exclusively Represents Hoover Pharmacy in their Sale to CVS

LOS ANGELES, March 28, 2023 /PRNewswire/ — M&A Healthcare Advisors (MAHA), a boutique merger and acquisition (M&A) advisory group, is proud to announce the sale of Hoover Pharmacy, a Specialty & Retail Pharmacy based in the San Francisco Bay area focused on serving Stanford Medical Campus patients. Hoover Pharmacy’s files were acquired by CVS and…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
M&A Healthcare Advisors (MAHA) Exclusively Represents Hoover Pharmacy in their Sale to CVS

LOS ANGELES, March 28, 2023 /PRNewswire/ — M&A Healthcare Advisors (MAHA), a boutique merger and acquisition (M&A) advisory group, is proud to announce the sale of Hoover Pharmacy, a Specialty & Retail Pharmacy based in the San Francisco Bay area focused on serving Stanford Medical Campus patients. Hoover Pharmacy’s files were acquired by CVS and all patients will now receive dispensing service at their local Palo Alto branch.

“Andre and his team were instrumental in driving value for our pharmacy and securing the ideal buyer to meet our specific sale criteria. His reliable and consistent guidance allowed us to focus on maintaining operations throughout the transaction while introducing a buyer that would faithfully continue our legacy of care with our patients across the bay area”, Jonathan Han, COO of Hoover Pharmacy.

While there is currently a sense of uncertainty in the larger economy, healthcare M&A remains active with the successful acquisition of Hoover being another great example of the resiliency of lower-middle market healthcare. The team at M&A Healthcare Advisors provided attentive and expert guidance, allowing the Hoover ownership team to achieve their unique sale goals on the identified timeline.

“We are very proud of the level of service we provide to our clients and the successful and efficient sale of Hoover Pharmacy speaks to the client-centric focus we strive for as an organization. Andre’s contributions and representation of the Hoover ownership team was commendable and demonstrates our belief that having an experienced and dedicated sell side advisor greatly increases the probability of achieving a successful outcome”, say Co-Founders Mark Thomas & Mike Moran.

This sale continues the tradition of excellence put in place by M&A Healthcare Advisors.

About M&A Healthcare Advisors

M&A Healthcare Advisors (MAHA), is a boutique merger and acquisition (M&A) advisory group, focused on the lower-middle market healthcare industry. Their core purpose is to provide comprehensive, efficient, and committed transactional support for emerging or established, lower-middle market healthcare businesses.

The team at M&A Healthcare Advisors has sold companies in a variety of healthcare segments: Behavioral Health, Autism Services, I/DD, Hospice, Home Health, Home Care, Private Duty, Physical Therapy, Staffing/Medical Recruiting, Facility-Based Care, Not-for-Profits, and all types of Pharmacy. Their full suite of services includes Sell-Side Representation, M&A Hourly Consulting, and Expert Valuation services.

Business Contact

Mark Thomas

Partner, Director of Operations

M&A Healthcare Advisors

mthomas@mahealthcareadvisors.com

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512